🇺🇸 Fluorouracil/Adrucil in United States
4 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 23 April 2025 – 23 April 2026
- Total reports: 4
Most-reported reactions
- Dyspnoea — 1 report (25%)
- Flushing — 1 report (25%)
- Infusion Related Reaction — 1 report (25%)
- Malaise — 1 report (25%)
Other Oncology approved in United States
Frequently asked questions
Is Fluorouracil/Adrucil approved in United States?
Fluorouracil/Adrucil does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Fluorouracil/Adrucil in United States?
Bristol-Myers Squibb is the originator. The local marketing authorisation holder may differ — check the official source linked above.